Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous paracetamol vs intravenous ibuprofen for treatment of patent ductus arteriosus in premature neonates
IRCT2016081729404N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetaminophen and ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: PDA closure and Safety outcomes. Started Mar 2017; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT2016081729404N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016081729404N1.